Redhill biopharma LTD-opaganib as host-directed therapeutic for ebola virus disease

Ended Definitive Contract Awarded Last action

Contract number
75A50124C00059
Awardee
Awarding agency
Obligated
$733,382

Award facts

Opportunity
  • BAA20SOL0002 Solicitation number
Contract value 100% obligated
$733,381.75 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Israel
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 $0
Original award $733,382

About this award

The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a $733,381.75 firm fixed price definitive contract to Redhill Biopharma LTD for development of opaganib as a host-directed therapeutic for Ebola virus disease on September 27, 2024.

Performance occurs in Israel. The contract is unset-aside and carries an ultimate completion date of March 31, 2026.

Quick answers

Who was awarded contract 75A50124C00059?

75A50124C00059 was awarded to Redhill Biopharma LTD by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 27, 2024.

How much is contract 75A50124C00059 worth?

The government has obligated $733,382 on 75A50124C00059.

Was contract 75A50124C00059 competed?

The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award